Cognition Disorders Terminated Phase 1 Trials for JNJ-39393406 (DB11867)

Also known as: Cognitive Disorder / Cognitive Disorders / Cognition Disorder / Cognitive Dysfunction / Cognitive Dysfunctions / Cognitive disorder (disorder)

IndicationStatusPhase
DBCOND0027877 (Cognition Disorders)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01137799The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic PatientsTreatment